Artia Global Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Artia Global Partners's ASND Position: Q3 2026 in Review
Artia Global Partners held its Ascendis Pharma (ASND) position steady in Q3 2026 at 17,740 shares worth $4.04M. The position accounts for 0.82% of the portfolio, ranked #29.
Artia Global Partners first reported a position in ASND in Q1 2024 and has held it in 11 quarters since. The position peaked at $4.73M in Q2 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Artia Global Partners held 17,740 shares of Ascendis Pharma worth $4.04M as of Q3 2026.
- Artia Global Partners left its Ascendis Pharma share count unchanged in Q3 2026.
- Ascendis Pharma made up 0.82% of Artia Global Partners's portfolio in Q3 2026, its #29 holding.
- Artia Global Partners first reported a position in Ascendis Pharma in Q1 2024 and has held it in 11 quarters since.
- Artia Global Partners's Ascendis Pharma position peaked at $4.73M in Q2 2026.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Artia Global Partners's 13F filing for Q3 2026, filed 16 Nov 2026.